{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:38:59Z","timestamp":1760150339038,"version":"build-2065373602"},"reference-count":26,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>Diffuse large B-cell lymphoma (DLBCL) and angioimmunoblastic T-cell lymphoma (AITL) are two subtypes of non-Hodgkin lymphoma (NHL). The simultaneous occurrence of DLBCL and AITL in a composite lymphoma is very rare, and there are no established treatment regimens. We present the case of an 85-year-old male admitted to the intensive care unit with distributive shock, lymphocytosis, and lymphadenopathy, who was subsequently diagnosed with composite AITL and DLBCL, and treated with brentuximab vedotin (BV) and rituximab. To our knowledge, this is the first case of composite lymphoma presenting with distributive shock and treated with BV and rituximab, with successful resolution of shock.<\/jats:p>","DOI":"10.3390\/hematolrep15040064","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T08:19:43Z","timestamp":1700122783000},"page":"627-633","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Composite Angioimmunoblastic T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma Presenting with Distributive Shock"],"prefix":"10.3390","volume":"15","author":[{"given":"Nisha","family":"Hariharan","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, University of California, La Jolla, CA 92093, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisha","family":"Kabadi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Critical Care, Sleep Medicine, and Physiology, University of California, La Jolla, CA 92093, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Don","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California, La Jolla, CA 92093, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen","family":"Odish","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Critical Care, Sleep Medicine, and Physiology, University of California, La Jolla, CA 92093, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6707-0861","authenticated-orcid":false,"given":"Benjamin","family":"Heyman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Regenerative Medicine, University of California, La Jolla, CA 92093, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"The Non-Hodgkin\u2019s Lymphoma Classification Project (1997). A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. Blood, 89, 3909\u20133918.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3324\/haematol.2016.148809","article-title":"Non-Hodgkin lymphoma in the developing world: Review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project","volume":"101","author":"Perry","year":"2016","journal-title":"Haematologica"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.critrevonc.2008.06.012","article-title":"Angioimmunoblastic T-cell lymphoma","volume":"68","author":"Iannitto","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1440-1827.2012.02858.x","article-title":"Clinicopathological analysis of a composite lymphoma containing both T- and B- cell lymphomas","volume":"62","author":"Suefuji","year":"2012","journal-title":"Pathol. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nri1201","article-title":"B cells under influence: Transformation of B cells by Epstein-Barr virus","volume":"3","author":"Kuppers","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/dc.21641","article-title":"Sequential development of diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma","volume":"40","author":"Huang","year":"2012","journal-title":"Diagn. Cytopathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1309\/VD2D-98ME-MB3F-WH34","article-title":"Composite angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma: A case report and review of the literature","volume":"118","author":"Xu","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2141.2008.07004.x","article-title":"Precursors of classical Hodgkin lymphoma in samples of angioimmunoblastic T-cell lymphoma","volume":"141","author":"Naresh","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1309\/6UTX-GVC0-12ND-JJEU","article-title":"Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified","volume":"117","author":"Zettl","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MOH.0b013e328186ffbf","article-title":"Angioimmunoblastic T cell lymphoma: Pathobiological insights and clinical implications","volume":"14","author":"Dunleavy","year":"2007","journal-title":"Curr. Opin. Hematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1182\/blood.2022015451","article-title":"Clonal germinal center B cells function as a niche for T-cell lymphoma","volume":"140","author":"Fujisawa","year":"2022","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood.2022017807","article-title":"A Tet-a-Tet in T follicular helper cell lymphoma","volume":"140","author":"Amengual","year":"2022","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/CCM.0000000000002990","article-title":"Urgent chemotherapy in sepsis-like shock related to hematologic malignancies","volume":"46","author":"Cherruault","year":"2018","journal-title":"Crit. Care Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.ccm.0000510401.90977.cf","article-title":"Refractory and progressive distributive shock due to angioimmunoblastic T cell lymphoma","volume":"44","author":"Reynolds","year":"2016","journal-title":"Crit. Care Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ncponc0430","article-title":"Sustained remission from angioimmunoblastic T-cell lymphoma induced by alemtuzumab","volume":"3","author":"Halene","year":"2006","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3109\/10428194.2011.555893","article-title":"Capillary leak syndrome: Initial presentation in a patient with ALK+ anaplastic large cell lymphoma associated with increased levels of serum cytokines","volume":"52","author":"Umemoto","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"ref_17","first-page":"954201","article-title":"Systemic capillary leak syndrome as an initial presentation of ALK-negative anaplastic large cell lymphoma","volume":"2012","author":"Lourdes","year":"2012","journal-title":"Case Rep. Hematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): A global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1182\/bloodadvances.2020002396","article-title":"T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed\/refractory peripheral T-cell lymphoma","volume":"4","author":"Ghione","year":"2020","journal-title":"Blood Adv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.humpath.2006.10.010","article-title":"Simultaneous occurrence of peripheral T-cell lymphoma unspecified and B-cell small lymphocytic lymphoma. Report of 2 cases","volume":"38","author":"Campidelli","year":"2007","journal-title":"Hum. Pathol."},{"key":"ref_21","first-page":"5473","article-title":"Composite angioimmunoblastic T cell\/diffuse large B-cell lymphoma treated with reduced-intensity conditioning HLA-haploidentical allo-HSCT: A case report and review of the literature","volume":"11","author":"Hong","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e31802d68e9","article-title":"Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: Clinical correlation and insights into natural history and disease progression","volume":"31","author":"Attygalle","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3324\/haematol.2019.238675","article-title":"Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas","volume":"106","author":"Svoboda","year":"2021","journal-title":"Haemtologica"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hon.2963","article-title":"Brentuximab vedotin in the treatment of relapsed\/refractory CD30+ peripheral T-cell lymphoma: A FIL phase 2 study","volume":"40","author":"Stefoni","year":"2022","journal-title":"Hematol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000488312","article-title":"Refractory septic shock due to underlying immunocompromised disease: A case of fatal peripheral T-cell lymphoma not otherwise specified in a young Hispanic woman","volume":"11","author":"Kumar","year":"2018","journal-title":"Case Rep. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"04612","DOI":"10.1002\/ccr3.4612","article-title":"Unexplained recurrent shock in peripheral T-cell lymphoma: A case report","volume":"9","author":"Imamura","year":"2021","journal-title":"Clin. Case Rep."}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/15\/4\/64\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:23:45Z","timestamp":1760131425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/15\/4\/64"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["hematolrep15040064"],"URL":"https:\/\/doi.org\/10.3390\/hematolrep15040064","relation":{},"ISSN":["2038-8330"],"issn-type":[{"type":"electronic","value":"2038-8330"}],"subject":[],"published":{"date-parts":[[2023,11,16]]}}}